The German government has pledged €51.35 million as part of a €56.5 million funding. Other countries and foundations are donating the balance, to advance the work of the Global Antibiotic Research and Development Partnership
New pact by major companies including Johnson & Johnson, Pfizer, Sanofi, AstraZeneca and Novartis follows vow by global leaders for greater effort against superbugs